FEIBA

Indicated For

hemophilia A with inhibitors, hemophilia B with inhibitors

About This Medication

# FEIBA Patient Guide: How to Get FEIBA at Low or No Cost FEIBA (Anti-Inhibitor Coagulant Complex), made by Takeda, is a vital treatment for people with hemophilia A or B who have developed inhibitors—antibodies that stop standard clotting factors from working. This guide explains how to access **Takeda's patient support services** for FEIBA at low or no cost, including eligibility, application steps, and more[1][2][4]. ## About FEIBA **FEIBA** is an FDA-approved bypassing agent used in patients with hemophilia A and B with inhibitors. It helps **control and prevent bleeding episodes**, manage bleeding around surgery (perioperative use), and provide **routine prophylaxis** to reduce bleeding frequency[1][2][4][6]. FEIBA works by providing activated clotting factors that bypass the inhibitors, promoting blood clot formation where it's needed. It's available in vials of **500, 1000, or 2500 units**, with color-coded packaging for easy identification. Patients can learn to self-infuse at home after training, using the BAXJECT II Hi-Flow device for quick reconstitution in three steps: connect diluent, connect FEIBA vial, withdraw solution[3][5]. Dosing is personalized by your doctor based on bleed type, your weight, and response. General guidelines include: - **Minor/moderate bleeds**: 50-100 units/kg every 6-12 hours until resolved. - **Major bleeds**: Up to 100 units/kg, adjusted as needed. - **Prophylaxis**: Often 85 units/kg every other day. - **Max limits**: No more than 100 units/kg per dose or 200 units/kg daily[2][3][7][8]. **Important risks**: FEIBA has a boxed warning for **embolic and thrombotic events** (blood clots). Discuss with your doctor; it's not for use in disseminated intravascular coagulation (DIC) or active clots[3][4]. Always use aseptic technique and follow prescribing info[2][5]. ## Who Qualifies for Assistance? Takeda offers **comprehensive patient support** through services focused on access, onboarding, and financial help for eligible patients prescribed FEIBA[1]. While specific income thresholds aren't detailed publicly, programs like these typically target: - U.S. residents with a valid FEIBA prescription. - Patients with hemophilia A or B and inhibitors. - Those facing high out-of-pocket costs, often uninsured or underinsured. Support includes **benefits investigation** to check insurance coverage and **financial assistance options** if eligible. Contact Takeda for personalized eligibility[1]. ## Income Eligibility Breakdown Exact income limits for Takeda's FEIBA program aren't specified in available resources, as they often align with **Federal Poverty Level (FPL)** percentages (e.g., 400-500% FPL) or are case-by-case. Here's a general table based on common pharmaceutical assistance structures—**confirm with Takeda** for FEIBA specifics: | Household Size | Estimated Annual Income Limit (e.g., 400% FPL) | Notes | |---------------|-----------------------------------------------|-------| | Individual | ~$60,000 | Varies by program; may include assets. | | Couple | ~$80,000 | Often up to 500% FPL for rare diseases. | | Family of 3 | ~$100,000 | Hemophilia patients prioritized. | | Family of 4 | ~$120,000 | Excludes certain income types. | These are illustrative; Takeda's team assesses household income, expenses, and medical needs[1]. No biosimilar alternatives to FEIBA are currently available[ ]. ## Insurance Requirements Takeda support works with **insured, uninsured, Medicare, or Medicaid patients**. Services include: - **Benefits investigation** to determine coverage. - Help with **prior authorizations (PA), reauthorizations, and appeals**[1]. If insured, you may still qualify for copay assistance or free medication if costs are high. Medicare patients often get bridge programs during PA delays. Always provide proof of insurance status[1]. ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your doctor for FEIBA and discuss support options. They can initiate benefits investigation[1][5]. 2. **Contact Takeda Support**: Call the number on feiba.com or your HCP portal (e.g., 1-XXX-XXX-XXXX—check site for current line). Request onboarding and financial assistance[1]. 3. **Submit Documents**: Expect to provide: - Proof of income (tax returns, pay stubs). - Prescription and diagnosis confirmation. - Insurance info or proof of uninsured status. - ID and household details[1]. 4. **Benefits Check**: Takeda verifies coverage and eligibility[1]. 5. **Approval & Enrollment**: If approved, sign enrollment forms. Medication ships directly or via specialty pharmacy[1]. Your doctor’s office often handles much of this via the "For Your Patients" portal[1]. ## Timeline and Delivery - **Processing**: Typically 1-2 weeks after complete submission, but benefits investigation is fast (days)[1]. - **Delivery**: Via specialty pharmacy to your home or doctor's office. Free shipping common[1]. Refills require reauthorization based on clinical need[1]. ## Alternatives if Denied - **Appeal**: Takeda helps with appeals and PAs[1]. - **Other Programs**: PAN Foundation, HealthWell Foundation for hemophilia (check eligibility). - **Patient Assistance**: Takeda's general programs or co-pay cards. - **Clinical Trials**: Search for FEIBA or bypassing agent studies. Discuss with your doctor for switches like other bypassing agents (e.g., rFVIIa), though FEIBA is unique for prophylaxis[3]. ## Disclaimer This guide is for informational purposes only and not medical or financial advice. Eligibility, terms, and availability change—**contact Takeda directly** via feiba.com or your healthcare provider for current details. Always follow your doctor's instructions for FEIBA use. Report side effects to FDA at 1-800-FDA-1088[1][2][4]. (Word count: 1028)

Program information last verified: March 30, 2026